These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 14658921)

  • 1. Refractory idiopathic immune thrombocytopenic purpura in children: current and future treatment options.
    Imbach P
    Paediatr Drugs; 2003; 5(12):795-801. PubMed ID: 14658921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of adult idiopathic thrombocytopenic purpura.
    Nakhoul IN; Kozuch P; Varma M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of immune thrombocytopenic purpura in children : current concepts.
    Shad AT; Gonzalez CE; Sandler SG
    Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of immune thrombocytopenic purpura in adults.
    Stasi R; Provan D
    Mayo Clin Proc; 2004 Apr; 79(4):504-22. PubMed ID: 15065616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic refractory idiopathic thrombocytopenic purpura (ITP) and anti-CD20 monoclonal antibody: a case report.
    Latifzadeh SZ; Entezari V
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):489-92. PubMed ID: 17000895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab treatment for chronic refractory idiopathic thrombocytopenic purpura.
    Zhou Z; Yang R
    Crit Rev Oncol Hematol; 2008 Jan; 65(1):21-31. PubMed ID: 17681784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura.
    Kojouri K; George JN
    Int J Hematol; 2005 Feb; 81(2):119-25. PubMed ID: 15765779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging drugs for idiopathic thrombocytopenic purpura in adults.
    Li X; Hou M
    Expert Opin Emerg Drugs; 2008 Jun; 13(2):237-54. PubMed ID: 18537519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
    Gómez-Almaguer D
    Hematology; 2012 Apr; 17 Suppl 1():S25-7. PubMed ID: 22507772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A clinical study of 103 idiopathic thrombocytopenic purpura].
    Fan Y; Chang NB; Xing BL; Li YM; Pei L; Li JT
    Zhonghua Nei Ke Za Zhi; 2008 Apr; 47(4):313-5. PubMed ID: 18843957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of chronic immune thrombocytopenic purpura in children and adults.
    Blanchette V; Freedman J; Garvey B
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):36-51. PubMed ID: 9523748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura.
    Arnold DM; Nazi I; Santos A; Chan H; Heddle NM; Warkentin TE; Kelton JG
    Blood; 2010 Jan; 115(1):29-31. PubMed ID: 19897578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of chronic idiopathic thrombocytopenic purpura in adults: experiences from Thailand.
    Wanachiwanawin W; Visudhiphan S; Pinankijagum A; Vatanavicharn S
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():71-5. PubMed ID: 7886612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic implications of T-cell clonopathy of unknown significance in chronic immune thrombocytopenic purpura.
    Sabnani I; Tsang P
    Platelets; 2009 Mar; 20(2):135-9. PubMed ID: 19235057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment options for chronic refractory idiopathic thrombocytopenic purpura in adults: focus on romiplostim and eltrombopag.
    Chouhan JD; Herrington JD
    Pharmacotherapy; 2010 Jul; 30(7):666-83. PubMed ID: 20575632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classical management of refractory adult immune (idiopathic) thrombocytopenic purpura.
    McMillan R
    Blood Rev; 2002 Mar; 16(1):51-5. PubMed ID: 11913996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab in the treatment of relapsing idiopathic thrombocytopenic purpura.
    Riksen NP; Keuning JJ; Vreugdenhil G
    Neth J Med; 2003 Jul; 61(7):262-5. PubMed ID: 14567524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.